Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of SARS-Cov-2 Antibodies in Children - a Prospective Multicentre Cohort Study

NCT04347408 is registered in ClinicalTrials.gov with Queen's University, Belfast as lead sponsor.

NCT NCT04347408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04347408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of SARS-Cov-2 Antibodies in Children - a Prospective Multicentre Cohort Study
Lead sponsor
Queen's University, Belfast
Phase
Observational
Overall status
Completed
Start date
May 6, 2020
Completion date
November 14, 2023
Enrollment
1,100 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid, multisystem inflammatory syndrome in children